Sierra Compounding, LLC, which operates as Sierra Pharmacy & Compounding Lab, has filed for Chapter 11 bankruptcy as a “small business debtor.” With this step, the Arizona-based pharmacy operator growing number pharmacy businesses that filed for bankruptcy in the past months.
Sierra Compounding, LLC Seeks Bankruptcy Protection
Sierra Compounding, LLC submitted a voluntary Chapter 11 petition on March 9, 2026, the latest case records on PACER. The filing was made under Subchapter V, indicating the company qualifies as a small business debtor under federal bankruptcy law.
The move is expected to allow the Arizona-based compounding pharmacy to restructure its debt while continuing operations. The Chapter 11 proceedings are being held in the U.S. Bankruptcy Court for the District of Arizona.
Sierra Compounding, LLC operates under the name Sierra Pharmacy & Compounding Lab, according to NPPES NPI Registry.
Filings So Far
According to PacerMonitor, attorney Patrick F. Keery of Keery McCue, PLLC is legally representing Sierra Compounding, LLC in the court. Further information listed in the Chapter 11 Subchapter V petition is:
- Filing Date: March 9, 2026
- Court and Jurisdiction: U.S. Bankruptcy Court for the District of Arizona
- Type of Filing: Active, Voluntary Petition, Subchapter V
- Chapter: 11
- Case Number: 4:26-bk-02156
- Estimated Assets: $100,001 to $500,000
- Estimated Liabilities: $1,000,001 to $10 million
- Reason for Filing: Restructure business under court supervision
Court documents indicate the company has between one and 49 creditors. Case filings also show that it submitted several documents to the court. These include a corporate resolution authorizing the bankruptcy, a financing statement report, an application for hiring counsel, and a disclosure of attorney compensation.
Sierra Compounding, LLC also submitted motions related to payment of employees, use of cash collateral, expedition of first-day motions, and approval of utility payments.
According to the filing, the pharmacy service provider has to submit Schedules A/B-J and a statement of financial affairs by March 23. The filing also indicates a creditors’ meeting is scheduled for April 16. Its Chapter 11 plan is due on June 8.
Company Background
Sierra Compounding, LLC, d.b.a. Sierra Pharmacy & Compounding Lab, provides medical solutions to patients based on their individual needs. As a compounding pharmacy service, its customized offerings are available in Sierra Vista.
In addition to compounding and prescription filling, the Arizona-based facility offers services, such as hormone replacement therapy consultations, vaccinations, automatic prescription refills, and telemedicine support. According to the company website, Sierra Compounding, LLC’s free medication delivery is available in Bisbee, Tombstone, and Huachuca City.
Previous Bankruptcy Filings by Pharmacy Companies
While Sierra Compounding, LLC faces bankruptcy in early 2026, the pharmacy sector has been affected for the past many months.
Uptown Pharmacy Of Kingman, Inc. is another Arizona-based independent pharmacy retailer, which made its filing on December 31, 2025. During that time, it had only one outlet, although the retailer served patients across Mohave County and Golden Valley. The petition details added that the pharmacy then owed around 50 to 99 creditors.
On September 22, 2025, a pharmaceutical manufacturer, APS-Summit Care Pharmacy, L.L.C., entered Chapter 11 bankruptcy. The filing aimed to reorganize the company’s finances after liabilities exceeded its assets. The manufacturer requested a joint administration of its case with APS Acquisition LLC, its parent company.
Whitehall Pharmacy LLC was one more independent pharmacy that pursued bankruptcy last year. Sharing its Chapter 11 petition on July 21, the company said that pending breach-of-contract lawsuits and pressures from national pharmacy giants pushed it to submit the petition.
With its latest filing, Sierra Compounding, LLC falls among a growing group of independent pharmacy operators facing financial troubles in the industry. The Chapter 11 process is expected to allow the Arizona-based compounding pharmacy to readjust its debts while continuing to serve patients.
